Stay updated on Double-Dose Levonorgestrel PK With Efavirenz/Rifampicin Clinical Trial
Sign up to get notified when there's something new on the Double-Dose Levonorgestrel PK With Efavirenz/Rifampicin Clinical Trial page.

Latest updates to the Double-Dose Levonorgestrel PK With Efavirenz/Rifampicin Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedNo additions or deletions were provided for this page.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed. This appears to be document versioning with no visible changes to the study details presented on the page.SummaryDifference0.0%

- Check34 days agoChange DetectedSite revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check63 days agoChange DetectedFooter now mentions Tuberculosis and includes a link to the Genetic and Rare Diseases Information Center. The revision tag has been updated from v3.4.1 to v3.4.2.SummaryDifference0.2%

- Check70 days agoChange DetectedThe only visible change is a footer revision update from v3.4.0 to v3.4.1, with no impact on study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check77 days agoChange DetectedUI updates include showing the glossary toggle and minor wording changes such as capitalization in 'Last Update Submitted' and 'QC Criteria' as well as a version reference updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Double-Dose Levonorgestrel PK With Efavirenz/Rifampicin Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Double-Dose Levonorgestrel PK With Efavirenz/Rifampicin Clinical Trial page.